+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Simulating demand for innovative radiotherapies: an illustrative model based on carbon ion and proton radiotherapy



Simulating demand for innovative radiotherapies: an illustrative model based on carbon ion and proton radiotherapy



RadioTherapy and Oncology 96(2): 243-249



Innovative therapies are not only characterized by major uncertainties regarding clinical benefit and cost but also the expected recruitment of patients. An original model was developed to simulate patient recruitment to a costly particle therapy by varying layout of the facility and patient referral (one vs. several countries) and by weighting the treated indication by the expected benefit of particle therapy. A multi-step probabilistic spatial model was used to allocate patients to the optimal treatment strategy and facility taking into account the estimated therapeutic gain from the new therapy for each tumour type, the geographical accessibility of the facilities and patient preference. Recruitment was simulated under different assumptions relating to the demand and supply. Extending the recruitment area, reducing treatment capacity, equipping all treatment rooms with a carbon ion gantry and inclusion of proton protocols in carbon ion facilities led to an increased proportion of indications with the highest expected benefit. Assuming the existence of a competing carbon ions facility, lower values of therapeutic gain, and a greater unwillingness of patients to travel for treatment increased the proportion of indications with low expected benefit. Modelling patient recruitment may aid decision-making when planning new and expensive treatments.

(PDF emailed within 0-6 h: $19.90)

Accession: 055783475

Download citation: RISBibTeXText

PMID: 20452693

DOI: 10.1016/j.radonc.2010.04.010


Related references

Measurement of neutron ambient dose equivalent in passive carbon-ion and proton radiotherapies. Medical Physics 35(11): 4782-4792, 2009

1 carbon 13 aldono 1 4 lactones conformational studies based on proton proton carbon 13 proton and carbon 13 carbon 13 spin couplings and ab initio molecular orbital calculations. Journal of the American Chemical Society 109(15): 4464-4472, 1987

Carbon 13 aldono 1 4 lactones conformational studies based on proton proton carbon 13 proton and carbon 13 carbon 13 spin couplings and ab initio molecular orbital calculations. Journal Of The American Chemical Society5: 4464-4472, 1987

A validated tumor control probability model based on a meta-analysis of low, intermediate, and high-risk prostate cancer patients treated by photon, proton, or carbon-ion radiotherapy. Medical Physics 43(2): 734-747, 2016

Determination of the Baseline Susceptibility of European Populations of Cydia pomonella (Lepidoptera: Tortricidae) to Chlorantraniliprole and the Role of Cytochrome P450 Monooxygenases. Journal of Economic Entomology, 2018

Measurement of absorbed dose, quality factor, and dose equivalent in water phantom outside of the irradiation field in passive carbon-ion and proton radiotherapies. Medical Physics 37(8): 4046-4055, 2010

New radiotherapy technologies for meningiomas: 3D conformal radiotherapy? Radiosurgery? Stereotactic radiotherapy? Intensity-modulated radiotherapy? Proton beam radiotherapy? Spot scanning proton radiation therapy... or nothing at all?. RadioTherapy and Oncology 71(3): 247-249, 2004

An innovative lattice Boltzmann model for simulating Michaelis-Menten-based diffusion-advection kinetics and its application within a cartilage cell bioreactor. Biomechanics and Modeling in Mechanobiology 9(2): 141-151, 2010

Re: new radiotherapy technologies for meningiomas: 3D conformal radiotherapy? Radiosurgery? Sterotactic radiotherapy? Intensity modulated radiotherapy? Proton beam radiotherapy? Spot scanning proton radiation therapy? Or nothing at all? [Radiother Oncol 2004;71(3):247-249. RadioTherapy and Oncology 73(2): 251-252, 2004

Innovative radiotherapy of sarcoma: Proton beam radiation. European Journal of Cancer 62: 112-123, 2016

Intensity-modulated radiotherapy versus proton radiotherapy versus carbon ion radiotherapy for spinal bone metastases: a treatment planning study. Journal of Applied Clinical Medical Physics 16(6): 5618-5618, 2016

Studies of proton translocations in biological systems: simulating proton transport in carbonic anhydrase by EVB-based models. Biophysical Journal 87(4): 2221-2239, 2004

L-PEACH, an L-systems based model for simulating the architecture and carbon partitioning of growing fruit trees. Acta Horticulturae (707): 71-76, 2006

Treatment Planning Comparison for Carbon Ion Radiotherapy, Proton Therapy and Intensity-modulated Radiotherapy for Spinal Sarcoma. Anticancer Research 35(7): 4083-4089, 2015

Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer. RadioTherapy and Oncology 101(3): 376-382, 2012